|
hsa02010 |
ABC transporters |
6 |
4 |
|
hsa05221 |
Acute myeloid leukemia |
61 |
31 |
|
hsa04520 |
Adherens junction |
49 |
23 |
|
hsa04920 |
Adipocytokine signaling pathway |
27 |
16 |
|
hsa04261 |
Adrenergic signaling in cardiomyocytes |
25 |
18 |
|
hsa05143 |
African trypanosomiasis |
3 |
3 |
|
hsa04933 |
AGE RAGE signaling pathway in diabetic complications |
58 |
26 |
|
hsa05034 |
Alcoholism |
39 |
25 |
|
hsa04960 |
Aldosterone regulated sodium reabsorption |
16 |
10 |
|
hsa04925 |
Aldosterone synthesis and secretion |
24 |
19 |
|
hsa05330 |
Allograft rejection |
5 |
4 |
|
hsa05010 |
Alzheimer disease |
108 |
61 |
|
hsa00520 |
Amino sugar and nucleotide sugar metabolism |
1 |
1 |
|
hsa05146 |
Amoebiasis |
28 |
16 |
|
hsa05031 |
Amphetamine addiction |
26 |
13 |
|
hsa04152 |
AMPK signaling pathway |
42 |
26 |
|
hsa05014 |
Amyotrophic lateral sclerosis |
65 |
37 |
|
hsa01523 |
Antifolate resistance |
10 |
5 |
|
hsa04612 |
Antigen processing and presentation |
14 |
12 |
|
hsa04371 |
Apelin signaling pathway |
56 |
34 |
|
hsa04210 |
Apoptosis |
83 |
41 |
|
hsa04215 |
Apoptosis multiple species |
17 |
10 |
|
hsa00590 |
Arachidonic acid metabolism |
1 |
1 |
|
hsa05412 |
Arrhythmogenic right ventricular cardiomyopathy |
23 |
12 |
|
hsa00053 |
Ascorbate and aldarate metabolism |
1 |
1 |
|
hsa05310 |
Asthma |
3 |
2 |
|
hsa05320 |
Autoimmune thyroid disease |
6 |
5 |
|
hsa04140 |
Autophagy animal |
55 |
34 |
|
hsa04136 |
Autophagy other |
8 |
6 |
|
hsa04360 |
Axon guidance |
54 |
34 |
|
hsa05100 |
Bacterial invasion of epithelial cells |
53 |
26 |
|
hsa05217 |
Basal cell carcinoma |
46 |
17 |
|
hsa03022 |
Basal transcription factors |
2 |
2 |
|
hsa03410 |
Base excision repair |
18 |
11 |
|
hsa04662 |
B cell receptor signaling pathway |
70 |
34 |
|
hsa00410 |
beta Alanine metabolism |
1 |
1 |
|
hsa04976 |
Bile secretion |
11 |
8 |
|
hsa01240 |
Biosynthesis of cofactors |
2 |
2 |
|
hsa01040 |
Biosynthesis of unsaturated fatty acids |
1 |
1 |
|
hsa05219 |
Bladder cancer |
73 |
21 |
|
hsa05224 |
Breast cancer |
135 |
54 |
|
hsa04020 |
Calcium signaling pathway |
55 |
36 |
|
hsa04024 |
cAMP signaling pathway |
75 |
42 |
|
hsa04973 |
Carbohydrate digestion and absorption |
9 |
4 |
|
hsa01200 |
Carbon metabolism |
1 |
1 |
|
hsa04260 |
Cardiac muscle contraction |
6 |
4 |
|
hsa04514 |
Cell adhesion molecules |
24 |
18 |
|
hsa04110 |
Cell cycle |
135 |
49 |
|
hsa04218 |
Cellular senescence |
134 |
56 |
|
hsa05230 |
Central carbon metabolism in cancer |
61 |
21 |
|
hsa04022 |
cGMP PKG signaling pathway |
64 |
40 |
|
hsa05142 |
Chagas disease |
53 |
29 |
|
hsa05204 |
Chemical carcinogenesis DNA adducts |
1 |
1 |
|
hsa05208 |
Chemical carcinogenesis reactive oxygen species |
78 |
35 |
|
hsa05207 |
Chemical carcinogenesis receptor activation |
112 |
53 |
|
hsa04062 |
Chemokine signaling pathway |
78 |
42 |
|
hsa04979 |
Cholesterol metabolism |
9 |
7 |
|
hsa05231 |
Choline metabolism in cancer |
62 |
26 |
|
hsa04725 |
Cholinergic synapse |
33 |
22 |
|
hsa05220 |
Chronic myeloid leukemia |
107 |
42 |
|
hsa04713 |
Circadian entrainment |
19 |
13 |
|
hsa04710 |
Circadian rhythm |
2 |
2 |
|
hsa05030 |
Cocaine addiction |
26 |
11 |
|
hsa04966 |
Collecting duct acid secretion |
1 |
1 |
|
hsa05210 |
Colorectal cancer |
102 |
38 |
|
hsa04610 |
Complement and coagulation cascades |
22 |
16 |
|
hsa05171 |
Coronavirus disease COVID 19 |
62 |
32 |
|
hsa04927 |
Cortisol synthesis and secretion |
17 |
13 |
|
hsa04625 |
C type lectin receptor signaling pathway |
71 |
31 |
|
hsa04934 |
Cushing syndrome |
88 |
39 |
|
hsa00270 |
Cysteine and methionine metabolism |
3 |
1 |
|
hsa04060 |
Cytokine cytokine receptor interaction |
46 |
33 |
|
hsa04623 |
Cytosolic DNA sensing pathway |
18 |
9 |
|
hsa05415 |
Diabetic cardiomyopathy |
34 |
19 |
|
hsa05414 |
Dilated cardiomyopathy |
23 |
15 |
|
hsa03030 |
DNA replication |
8 |
7 |
|
hsa04728 |
Dopaminergic synapse |
21 |
15 |
|
hsa00982 |
Drug metabolism cytochrome P450 |
1 |
1 |
|
hsa00983 |
Drug metabolism other enzymes |
2 |
2 |
|
hsa04512 |
ECM receptor interaction |
26 |
15 |
|
hsa01521 |
EGFR tyrosine kinase inhibitor resistance |
60 |
31 |
|
hsa04961 |
Endocrine and other factor regulated calcium reabsorption |
13 |
11 |
|
hsa01522 |
Endocrine resistance |
113 |
41 |
|
hsa04144 |
Endocytosis |
103 |
59 |
|
hsa05213 |
Endometrial cancer |
87 |
28 |
|
hsa05120 |
Epithelial cell signaling in Helicobacter pylori infection |
39 |
16 |
|
hsa05169 |
Epstein Barr virus infection |
143 |
58 |
|
hsa04012 |
ErbB signaling pathway |
95 |
37 |
|
hsa04915 |
Estrogen signaling pathway |
66 |
35 |
|
hsa03460 |
Fanconi anemia pathway |
24 |
11 |
|
hsa00061 |
Fatty acid biosynthesis |
1 |
1 |
|
hsa01212 |
Fatty acid metabolism |
2 |
2 |
|
hsa04664 |
Fc epsilon RI signaling pathway |
39 |
21 |
|
hsa04666 |
Fc gamma R mediated phagocytosis |
55 |
31 |
|
hsa04216 |
Ferroptosis |
14 |
3 |
|
hsa05418 |
Fluid shear stress and atherosclerosis |
87 |
37 |
|
hsa04510 |
Focal adhesion |
111 |
54 |
|
hsa04068 |
FoxO signaling pathway |
88 |
47 |
|
hsa04727 |
GABAergic synapse |
16 |
9 |
|
hsa04540 |
Gap junction |
37 |
18 |
|
hsa04971 |
Gastric acid secretion |
11 |
7 |
|
hsa05226 |
Gastric cancer |
119 |
47 |
|
hsa05214 |
Glioma |
79 |
27 |
|
hsa04922 |
Glucagon signaling pathway |
17 |
13 |
|
hsa04724 |
Glutamatergic synapse |
19 |
13 |
|
hsa00564 |
Glycerophospholipid metabolism |
1 |
1 |
|
hsa00260 |
Glycine, serine and threonine metabolism |
1 |
1 |
|
hsa00531 |
Glycosaminoglycan degradation |
1 |
1 |
|
hsa00604 |
Glycosphingolipid biosynthesis ganglio series |
1 |
1 |
|
hsa00603 |
Glycosphingolipid biosynthesis globo and isoglobo series |
1 |
1 |
|
hsa00563 |
Glycosylphosphatidylinositol (GPI) anchor biosynthesis |
1 |
1 |
|
hsa00630 |
Glyoxylate and dicarboxylate metabolism |
1 |
1 |
|
hsa04929 |
GnRH secretion |
29 |
19 |
|
hsa04912 |
GnRH signaling pathway |
52 |
24 |
|
hsa05332 |
Graft versus host disease |
4 |
4 |
|
hsa04935 |
Growth hormone synthesis, secretion and action |
55 |
33 |
|
hsa04340 |
Hedgehog signaling pathway |
11 |
8 |
|
hsa04640 |
Hematopoietic cell lineage |
27 |
19 |
|
hsa05161 |
Hepatitis B |
148 |
63 |
|
hsa05160 |
Hepatitis C |
107 |
41 |
|
hsa05225 |
Hepatocellular carcinoma |
118 |
51 |
|
hsa05168 |
Herpes simplex virus 1 infection |
87 |
39 |
|
hsa04066 |
HIF 1 signaling pathway |
57 |
27 |
|
hsa04390 |
Hippo signaling pathway |
75 |
37 |
|
hsa04392 |
Hippo signaling pathway multiple species |
12 |
6 |
|
hsa03440 |
Homologous recombination |
25 |
12 |
|
hsa05163 |
Human cytomegalovirus infection |
158 |
64 |
|
hsa05170 |
Human immunodeficiency virus 1 infection |
107 |
56 |
|
hsa05165 |
Human papillomavirus infection |
192 |
91 |
|
hsa05166 |
Human T cell leukemia virus 1 infection |
165 |
72 |
|
hsa05016 |
Huntington disease |
55 |
33 |
|
hsa05410 |
Hypertrophic cardiomyopathy |
21 |
14 |
|
hsa04657 |
IL 17 signaling pathway |
34 |
16 |
|
hsa05321 |
Inflammatory bowel disease |
32 |
13 |
|
hsa04750 |
Inflammatory mediator regulation of TRP channels |
17 |
10 |
|
hsa05164 |
Influenza A |
54 |
30 |
|
hsa00562 |
Inositol phosphate metabolism |
11 |
8 |
|
hsa04931 |
Insulin resistance |
41 |
24 |
|
hsa04911 |
Insulin secretion |
16 |
13 |
|
hsa04910 |
Insulin signaling pathway |
60 |
34 |
|
hsa04672 |
Intestinal immune network for IgA production |
8 |
6 |
|
hsa04630 |
JAK STAT signaling pathway |
81 |
40 |
|
hsa05167 |
Kaposi sarcoma associated herpesvirus infection |
150 |
56 |
|
hsa05134 |
Legionellosis |
24 |
14 |
|
hsa05140 |
Leishmaniasis |
33 |
17 |
|
hsa04670 |
Leukocyte transendothelial migration |
36 |
19 |
|
hsa05417 |
Lipid and atherosclerosis |
115 |
56 |
|
hsa04211 |
Longevity regulating pathway |
60 |
30 |
|
hsa04213 |
Longevity regulating pathway multiple species |
35 |
21 |
|
hsa04730 |
Long term depression |
18 |
14 |
|
hsa04720 |
Long term potentiation |
21 |
15 |
|
hsa00310 |
Lysine degradation |
14 |
7 |
|
hsa04142 |
Lysosome |
18 |
18 |
|
hsa05144 |
Malaria |
13 |
10 |
|
hsa04010 |
MAPK signaling pathway |
167 |
85 |
|
hsa04950 |
Maturity onset diabetes of the young |
2 |
2 |
|
hsa05162 |
Measles |
101 |
43 |
|
hsa04916 |
Melanogenesis |
29 |
21 |
|
hsa05218 |
Melanoma |
79 |
28 |
|
hsa01100 |
Metabolic pathways |
48 |
36 |
|
hsa00980 |
Metabolism of xenobiotics by cytochrome P450 |
1 |
1 |
|
hsa05206 |
MicroRNAs in cancer |
176 |
73 |
|
hsa04978 |
Mineral absorption |
7 |
6 |
|
hsa03430 |
Mismatch repair |
10 |
7 |
|
hsa04137 |
Mitophagy animal |
58 |
20 |
|
hsa05032 |
Morphine addiction |
10 |
9 |
|
hsa03015 |
mRNA surveillance pathway |
4 |
4 |
|
hsa04150 |
mTOR signaling pathway |
52 |
34 |
|
hsa04650 |
Natural killer cell mediated cytotoxicity |
50 |
30 |
|
hsa04217 |
Necroptosis |
22 |
18 |
|
hsa04080 |
Neuroactive ligand receptor interaction |
24 |
20 |
|
hsa04722 |
Neurotrophin signaling pathway |
94 |
45 |
|
hsa04613 |
Neutrophil extracellular trap formation |
51 |
26 |
|
hsa04064 |
NF kappa B signaling pathway |
37 |
22 |
|
hsa00510 |
N Glycan biosynthesis |
1 |
1 |
|
hsa05033 |
Nicotine addiction |
3 |
2 |
|
hsa04621 |
NOD like receptor signaling pathway |
50 |
26 |
|
hsa04932 |
Non alcoholic fatty liver disease |
52 |
25 |
|
hsa03450 |
Non homologous end joining |
6 |
6 |
|
hsa05223 |
Non small cell lung cancer |
78 |
29 |
|
hsa04330 |
Notch signaling pathway |
28 |
16 |
|
hsa03013 |
Nucleocytoplasmic transport |
8 |
6 |
|
hsa03420 |
Nucleotide excision repair |
8 |
6 |
|
hsa04740 |
Olfactory transduction |
5 |
4 |
|
hsa04114 |
Oocyte meiosis |
36 |
22 |
|
hsa04380 |
Osteoclast differentiation |
70 |
33 |
|
hsa00511 |
Other glycan degradation |
1 |
1 |
|
hsa04913 |
Ovarian steroidogenesis |
7 |
5 |
|
hsa04921 |
Oxytocin signaling pathway |
74 |
35 |
|
hsa04115 |
p53 signaling pathway |
58 |
19 |
|
hsa05212 |
Pancreatic cancer |
85 |
34 |
|
hsa04972 |
Pancreatic secretion |
11 |
8 |
|
hsa04928 |
Parathyroid hormone synthesis, secretion and action |
42 |
25 |
|
hsa05012 |
Parkinson disease |
41 |
21 |
|
hsa05130 |
Pathogenic Escherichia coli infection |
78 |
44 |
|
hsa05200 |
Pathways in cancer |
289 |
144 |
|
hsa05022 |
Pathways of neurodegeneration multiple diseases |
123 |
77 |
|
hsa05235 |
PD L1 expression and PD 1 checkpoint pathway in cancer |
82 |
42 |
|
hsa00040 |
Pentose and glucuronate interconversions |
1 |
1 |
|
hsa04146 |
Peroxisome |
7 |
5 |
|
hsa05133 |
Pertussis |
29 |
14 |
|
hsa04145 |
Phagosome |
21 |
16 |
|
hsa00360 |
Phenylalanine metabolism |
1 |
1 |
|
hsa04070 |
Phosphatidylinositol signaling system |
15 |
10 |
|
hsa04072 |
Phospholipase D signaling pathway |
55 |
30 |
|
hsa04151 |
PI3K Akt signaling pathway |
185 |
86 |
|
hsa04611 |
Platelet activation |
42 |
24 |
|
hsa01524 |
Platinum drug resistance |
57 |
21 |
|
hsa00860 |
Porphyrin and chlorophyll metabolism |
1 |
1 |
|
hsa03320 |
PPAR signaling pathway |
3 |
3 |
|
hsa00120 |
Primary bile acid biosynthesis |
2 |
2 |
|
hsa05340 |
Primary immunodeficiency |
21 |
14 |
|
hsa05020 |
Prion disease |
46 |
31 |
|
hsa04914 |
Progesterone mediated oocyte maturation |
43 |
26 |
|
hsa04917 |
Prolactin signaling pathway |
47 |
23 |
|
hsa00640 |
Propanoate metabolism |
1 |
1 |
|
hsa05215 |
Prostate cancer |
119 |
47 |
|
hsa04974 |
Protein digestion and absorption |
5 |
5 |
|
hsa03060 |
Protein export |
3 |
3 |
|
hsa04141 |
Protein processing in endoplasmic reticulum |
23 |
18 |
|
hsa05205 |
Proteoglycans in cancer |
146 |
69 |
|
hsa04964 |
Proximal tubule bicarbonate reclamation |
1 |
1 |
|
hsa00230 |
Purine metabolism |
6 |
6 |
|
hsa00240 |
Pyrimidine metabolism |
1 |
1 |
|
hsa00620 |
Pyruvate metabolism |
1 |
1 |
|
hsa04015 |
Rap1 signaling pathway |
80 |
48 |
|
hsa04014 |
Ras signaling pathway |
79 |
44 |
|
hsa04810 |
Regulation of actin cytoskeleton |
90 |
45 |
|
hsa04923 |
Regulation of lipolysis in adipocytes |
17 |
8 |
|
hsa04926 |
Relaxin signaling pathway |
62 |
30 |
|
hsa05211 |
Renal cell carcinoma |
56 |
28 |
|
hsa04614 |
Renin angiotensin system |
2 |
2 |
|
hsa04924 |
Renin secretion |
13 |
10 |
|
hsa00830 |
Retinol metabolism |
1 |
1 |
|
hsa04723 |
Retrograde endocannabinoid signaling |
12 |
9 |
|
hsa05323 |
Rheumatoid arthritis |
19 |
10 |
|
hsa00740 |
Riboflavin metabolism |
1 |
1 |
|
hsa03010 |
Ribosome |
1 |
1 |
|
hsa03008 |
Ribosome biogenesis in eukaryotes |
1 |
1 |
|
hsa04622 |
RIG I like receptor signaling pathway |
27 |
16 |
|
hsa03018 |
RNA degradation |
11 |
8 |
|
hsa04970 |
Salivary secretion |
10 |
8 |
|
hsa05132 |
Salmonella infection |
80 |
45 |
|
hsa04726 |
Serotonergic synapse |
24 |
15 |
|
hsa05131 |
Shigellosis |
117 |
57 |
|
hsa04550 |
Signaling pathways regulating pluripotency of stem cells |
64 |
32 |
|
hsa05222 |
Small cell lung cancer |
92 |
29 |
|
hsa04130 |
SNARE interactions in vesicular transport |
1 |
1 |
|
hsa04071 |
Sphingolipid signaling pathway |
51 |
24 |
|
hsa05017 |
Spinocerebellar ataxia |
35 |
21 |
|
hsa03040 |
Spliceosome |
15 |
14 |
|
hsa05150 |
Staphylococcus aureus infection |
6 |
5 |
|
hsa00100 |
Steroid biosynthesis |
1 |
1 |
|
hsa00140 |
Steroid hormone biosynthesis |
1 |
1 |
|
hsa04721 |
Synaptic vesicle cycle |
7 |
7 |
|
hsa05322 |
Systemic lupus erythematosus |
13 |
11 |
|
hsa04742 |
Taste transduction |
11 |
9 |
|
hsa04660 |
T cell receptor signaling pathway |
81 |
42 |
|
hsa00900 |
Terpenoid backbone biosynthesis |
1 |
1 |
|
hsa04350 |
TGF beta signaling pathway |
33 |
19 |
|
hsa04659 |
Th17 cell differentiation |
71 |
36 |
|
hsa04658 |
Th1 and Th2 cell differentiation |
55 |
29 |
|
hsa04714 |
Thermogenesis |
25 |
19 |
|
hsa05216 |
Thyroid cancer |
47 |
17 |
|
hsa04919 |
Thyroid hormone signaling pathway |
94 |
38 |
|
hsa04918 |
Thyroid hormone synthesis |
10 |
9 |
|
hsa04530 |
Tight junction |
55 |
32 |
|
hsa04668 |
TNF signaling pathway |
50 |
27 |
|
hsa04620 |
Toll like receptor signaling pathway |
53 |
27 |
|
hsa05145 |
Toxoplasmosis |
41 |
28 |
|
hsa05202 |
Transcriptional misregulation in cancer |
120 |
60 |
|
hsa00380 |
Tryptophan metabolism |
1 |
1 |
|
hsa05152 |
Tuberculosis |
53 |
32 |
|
hsa04940 |
Type I diabetes mellitus |
3 |
3 |
|
hsa04930 |
Type II diabetes mellitus |
23 |
14 |
|
hsa00350 |
Tyrosine metabolism |
2 |
2 |
|
hsa04120 |
Ubiquitin mediated proteolysis |
50 |
23 |
|
hsa00513 |
Various types of N glycan biosynthesis |
1 |
1 |
|
hsa04270 |
Vascular smooth muscle contraction |
20 |
14 |
|
hsa04962 |
Vasopressin regulated water reabsorption |
9 |
8 |
|
hsa04370 |
VEGF signaling pathway |
42 |
21 |
|
hsa05110 |
Vibrio cholerae infection |
8 |
5 |
|
hsa05203 |
Viral carcinogenesis |
137 |
55 |
|
hsa05416 |
Viral myocarditis |
21 |
11 |
|
hsa04061 |
Viral protein interaction with cytokine and cytokine receptor |
9 |
5 |
|
hsa04977 |
Vitamin digestion and absorption |
1 |
1 |
|
hsa04310 |
Wnt signaling pathway |
84 |
33 |
|
hsa05135 |
Yersinia infection |
101 |
47 |